MedTrace Logo

A Study in Adolescent Females to Explore Cytomegalovirus Infection

NCT01691820 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 369

Last updated 2021-04-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to estimate the incidence of Cytomegalovirus (CMV) secondary infections (re-infections/re-activations) and the incidence of CMV primary infections in adolescent females.

Conditions

  • Infections, Cytomegalovirus

Interventions

PROCEDURE

Blood collection

Samples collected at Months 0, 4, 8, 12, 16, 20, 24, 28, 32, and 36.

PROCEDURE

Urine collection

Samples collected at Months 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, and 36.

PROCEDURE

Saliva collection

Samples collected at Months 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, and 36.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
17 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-05
Primary Completion
2017-04-08
Completion
2017-04-08

Countries

  • United States
  • Finland
  • Mexico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01691820 on ClinicalTrials.gov